The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 27, 2021
Filed:
Oct. 30, 2019
Gilead Sciences, Inc., Foster City, CA (US);
Gayatri Balan, Bellevue, WA (US);
Mark J. Bartlett, Castro Valley, CA (US);
Jayaraman Chandrasekhar, Redmond, WA (US);
Julian A. Codelli, Seattle, WA (US);
John H. Conway, Seattle, WA (US);
Jennifer L. Cosman, Foster City, CA (US);
Rao V. Kalla, Cupertino, CA (US);
Musong Kim, Bellevue, WA (US);
Seung H. Lee, Sammamish, WA (US);
Jennifer R. Lo, Seattle, WA (US);
Jennifer A. Loyer-Drew, Seattle, WA (US);
Scott A. Mitchell, Kenmore, WA (US);
Thao D. Perry, San Jose, CA (US);
Gary B. Phillips, Issaquah, WA (US);
Patrick J. Salvo, Burien, WA (US);
Joshua J. Van Veldhuizen, Seattle, WA (US);
Suet C. Yeung, Redmond, WA (US);
Jeff Zablocki, Los Altos, CA (US);
Gilead Sciences, Inc., Foster City, CA (US);
Abstract
The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.